Meetings

A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to 12 mmHg on average at three months in patients whose blood pressure had remained uncontrolled despite compliance with their medication regimen, according to a study presented at the American College of Cardiology’s Annual Scientific Session.

People with hypertension and obstructive sleep apnea were no less likely to see their blood pressure drop over six months if they used a mandibular advancement device (MAD), which is inserted onto the teeth similar to a bite guard. compared to a continuous positive airway pressure (CPAP) device, according to research featured at the American College of Cardiology’s Annual Scientific Session.

Use of the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin following a heart attack did not show a significant benefit in reducing overall heart failure hospitalizations or death from any cause, according to a study presented at the American College of Cardiology’s Annual Scientific Session.

The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at the American College of Cardiology’s Annual Scientific Session. However, the findings suggest that the strategy may be beneficial with longer follow-up.

The Cardiovascular Research Foundation^® (CRF^®) is excited to introduce New York Valves: The Structural Heart Summit, the expanded next iteration of our renowned annual Transcatheter Valve Therapy (TVT^®) conference. Taking place June 5-7, 2024, at the Jacob K. Javits Convention Center, North in New York City, the new summit will be a world-class educational experience in the field of structural heart interventions.

Leaders from the Mass General Cancer Center, a member of the Mass General Brigham healthcare system, will present research discoveries and outcomes from clinical trials in cancer at the 2024 American Association for Cancer Research (AACR) Annual Meeting, held April 5-10, in San Diego.

• The conference convenes under the theme AI for All: Bridging Divides, Building a Sustainable Future, featuring over 25 sessions in 3 thematic tracks.
• The conference welcomes around 50 Ministers of ICTs and senior officials from over 20 countries and over 120 speakers from 30-plus countries.
• The UNU AI Network will be officially launched at this conference.
• Register at https://aimacau-2024.org/

Space weather impacts satellites, communications, GPS and power grids. TESS unites the community dedicated to the study of the Sun and its interactions with Earth and the other worlds in the solar system.Space weather impacts satellites, communications, GPS and power grids. TESS unites the community dedicated to the study of the Sun and its interactions with Earth and the other worlds in the solar system.Space weather impacts satellites, communications, GPS and power grids. TESS unites the community dedicated to the study of the Sun and its interactions with Earth and the other worlds in the solar system.Space weather impacts satellites, communications, GPS and power grids. TESS unites the community dedicated to the study of the Sun and its interactions with Earth and the other worlds in the solar system.